Inhalt des Dokuments
Dr.-Ing. Jan-Niklas Voigt-Antons
- © Copyright??
Jan-Niklas Voigt-Antons joined the Telekom Innovation Laboratories as a research scientist in January 2009 and is working there since 2014 as a senior research scientist. He received his diploma in psychology in 2008 from the Technische Universität Darmstadt, Germany, a Doctor-of-Engineering degree in 2014 from the Technische Universität Berlin, Germany and has been doing research at the Quality and Usability Lab at the Technische Universität (TU) Berlin, since. His research interests are in Quality-of-Experience evaluation and its physiological correlates with an emphasis on media transmissions and human-machine-interaction, including neural processing of multimodal interaction. During summer 2012 he was visiting researcher at MuSAE Lab (INRS-EMT), Canada where he examined neural correlates of quality perception for complex speech signals. In spring 2014 he was visiting researcher at the department of psychology of NTNU, Norway where he examined neural correlates of audiovisual asynchrony.
QULab research group: Quality , User Experience, Augmented
and Virtual Reality
• Multimedia Experience (Usability evaluation methods, Quality-of-Experience evaluation physiological measures)
• Interaction Design (Adaptive software, data mining, sensor and behavioural data)
Measuring of immersive media experience
Exergaming in virtual reality 
DemTab - Tabletgestützte ambulante Versorgung von Menschen mit Demenz 
VoiceAdapt - Adaptives Sprachtraining für ältere Menschen mit Aphasie 
OurPuppet - Pflegeunterstützung mit einer interaktiven Puppe für informell Pflegende 
PflegeTab - Technik für mehr Lebensqualität trotz Pflegebedürftigkeit bei Demenz (GKV) 
Quality of Mobile Gaming 
Bernstein Focus Neurotechnology - Berlin (BFNT - B) 
|Project||Study Project Quality
& Usability (6/9 CP)
Current thesis offers of our lab can be found here . Please contact me via email if you are interested in doing a thesis supervised by me.
Current job offers of our lab can be found here .
+49 30 8353 58 377
AddressTechnische Univertistät Berlin
Quality and Usability Lab
Telekom Innovation Laboratories
10587 Berlin, Germany
|Autor||Lech, Sonia and O'Sullivan, Julie and Voigt-Antons, Jan-Niklas and Gellert, Paul and Nordheim, Johanna|
|Buchtitel||Abstracts of the 14th International Congress of the European Geriatric Medicine Society|
|Verlag||Springer International Publishing|
|Organisation||European Geriatric Medicine Society|
|Zusammenfassung||Background: The current S3 Dementia Guideline is often not enoughimplemented in the care practice. Accordingly, the outpatient care ofpeople with dementia is often poor. Thus, integrated, cross-sectoraland guideline-oriented approaches are needed in order to improve thecare and life quality of people with dementia. Information andcommunication technologies (ICTs) such as tablets have greatpotential in this context, since they can support GPs and specialists inpatient-centered and guideline-oriented diagnostics and therapy.Further, ICTs enable patients, their caregivers and other carers toimplement effective therapeutic approaches in the home environment and can contribute to the improvement of intra and intersectoralhealth care. The objectives of the presented project ‘‘DemTab—Tablet-based outpatient care of people with dementia: guideline-based treatment planning, individual health management and net-working’’ are the development and scientific evaluation of a tabletbased intervention as an improvement of outpatient dementia care.Method: Within the framework of DemTab, a qualitative feasibilitystudy will be carried out to test a tablet-based intervention in everydayoutpatient care. The feasibility study takes into account the needs ofpatients with dementia and their caregivers as well as GPs in order todevelop, document and systematically evaluate a tablet-based inter-vention (mixed methods approach). In a second step, the developedtablet-based intervention will be tested. In a cluster randomizedcontrol study, GPs (N = 20) and their patients with dementia togetherwith their caregivers (N = 204) will be randomly assigned to anintervention (N = 102) and a control (N = 102) group. Clinical out-comes will be measured at baseline, after 9-months and after12-months using standardized and validated measurements as well ascontinually using the tablet and medical records data.Results: The study design of DemTab and the first results of the fea-sibility study will be presented. Based on the feasibility study, firstcontents and applications of the tablet will be presented and discussed.|